科华生物
(002022)
| 流通市值：30.80亿 | | | 总市值：30.81亿 |
| 流通股本：5.14亿 | | | 总股本：5.14亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 874,987,252.95 | 817,502,589.16 | 787,309,260.67 | 864,626,234.89 |
| 交易性金融资产 | 299,624.1 | 274,487.85 | 278,509.65 | 293,591.4 |
| 应收票据及应收账款 | 751,631,342.56 | 832,642,233.07 | 872,707,704.51 | 877,621,178.02 |
| 其中：应收票据 | 6,174,026.59 | 11,236,897.68 | 8,299,340.85 | 6,319,069.02 |
| 应收账款 | 745,457,315.97 | 821,405,335.39 | 864,408,363.66 | 871,302,109 |
| 应收款项融资 | 6,381,784.19 | 12,837,294.94 | 11,782,600.48 | 6,595,820.95 |
| 预付款项 | 100,238,173.58 | 102,249,542.99 | 112,420,057.97 | 89,516,194.79 |
| 其他应收款合计 | 32,739,975.22 | 13,425,557.46 | 14,291,136.82 | 15,345,739.65 |
| 存货 | 832,418,619.38 | 843,870,623.24 | 867,320,643.11 | 875,200,497.27 |
| 其他流动资产 | 117,825,503.77 | 116,525,349.79 | 115,643,981.84 | 107,219,456.7 |
| 流动资产合计 | 2,716,522,275.75 | 2,739,327,678.5 | 2,781,753,895.05 | 2,836,418,713.67 |
| 非流动资产: | | | | |
| 长期应收款 | 24,520,242.62 | 24,466,360.17 | 28,068,426.83 | 26,938,842.32 |
| 长期股权投资 | 3,282,839.58 | 3,322,480.87 | 3,369,644.69 | 3,504,797.43 |
| 其他权益工具投资 | 23,393,686 | 23,393,686 | 23,393,686 | 23,393,686 |
| 投资性房地产 | 345,862.89 | 567,125.84 | 571,570.54 | 576,015.25 |
| 固定资产 | 821,558,490.7 | 839,665,991.29 | 797,268,974.48 | 802,484,780.76 |
| 在建工程 | 564,310.33 | 1,640,045.17 | 2,296,398.38 | 3,577,432.37 |
| 使用权资产 | 53,386,102.46 | 52,806,026.37 | 56,634,298.37 | 52,657,617.37 |
| 无形资产 | 376,230,251.91 | 380,726,082.6 | 370,977,474.45 | 382,804,313.7 |
| 开发支出 | 180,372,583 | 176,225,345.04 | 165,832,028.2 | 151,161,325.35 |
| 商誉 | 677,189,089.12 | 678,593,752.54 | 665,941,345.97 | 660,295,559.04 |
| 长期待摊费用 | 39,975,689.28 | 47,912,848.42 | 49,366,275.92 | 41,598,881.85 |
| 递延所得税资产 | 239,082,216.17 | 236,024,999.37 | 234,816,825.44 | 232,628,293.88 |
| 其他非流动资产 | 13,783,438 | 12,978,066.83 | 15,417,750.83 | 18,087,793.85 |
| 非流动资产合计 | 2,453,684,802.06 | 2,478,322,810.51 | 2,413,954,700.1 | 2,399,709,339.17 |
| 资产总计 | 5,170,207,077.81 | 5,217,650,489.01 | 5,195,708,595.15 | 5,236,128,052.84 |
| 流动负债: | | | | |
| 短期借款 | 309,419,850.98 | 232,011,785.8 | 141,412,523.73 | 83,422,498.53 |
| 应付票据及应付账款 | 305,922,438.79 | 293,649,294.1 | 299,710,367.72 | 276,236,208.23 |
| 其中：应付票据 | 34,559,973.83 | 19,289,606.06 | 5,150,419.2 | 6,504,316.8 |
| 应付账款 | 271,362,464.96 | 274,359,688.04 | 294,559,948.52 | 269,731,891.43 |
| 合同负债 | 118,368,577.95 | 113,410,746.66 | 110,470,019.12 | 114,552,836.62 |
| 应付职工薪酬 | 70,061,041.12 | 64,006,145.93 | 53,808,322.28 | 97,354,111.09 |
| 应交税费 | 10,518,513.96 | 9,814,927.07 | 17,930,341.16 | 12,011,202.35 |
| 其他应付款合计 | 125,016,687.06 | 124,287,548.84 | 128,545,702.3 | 168,048,275.7 |
| 其中:应付利息 | 799,888.57 | 3,128,205.28 | 2,294,814.44 | 1,453,158.23 |
| 应付股利 | 38,000,000 | 38,000,000 | 38,000,000 | 77,697,150 |
| 一年内到期的非流动负债 | 280,718,681.75 | 60,778,296.77 | 60,117,340.15 | 59,644,596.74 |
| 其他流动负债 | 10,474,980.76 | 19,651,979.53 | 9,266,996.48 | 8,563,765.22 |
| 流动负债合计 | 1,230,500,772.37 | 917,610,724.7 | 821,261,612.94 | 819,833,494.48 |
| 非流动负债: | | | | |
| 长期借款 | 68,176,757.42 | 78,038,294.26 | 80,388,201.53 | 86,444,505.36 |
| 应付债券 | - | 218,362,030.6 | 216,301,983.65 | 214,298,130.39 |
| 租赁负债 | 25,640,756.86 | 25,743,967.77 | 30,934,735.06 | 25,942,012.66 |
| 预计负债 | 59,545,620.5 | 74,884,867.87 | 66,685,205.95 | 62,148,575.21 |
| 递延收益 | 30,130,749.78 | 31,905,390.71 | 32,724,503.16 | 34,563,639 |
| 递延所得税负债 | 9,455,992.99 | 9,970,607.03 | 10,009,176.47 | 10,516,973.46 |
| 非流动负债合计 | 192,949,877.55 | 438,905,158.24 | 437,043,805.82 | 433,913,836.08 |
| 负债合计 | 1,423,450,649.92 | 1,356,515,882.94 | 1,258,305,418.76 | 1,253,747,330.56 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 514,348,244 | 514,318,459 | 514,318,121 | 514,317,589 |
| 其他权益工具 | 43,391,363.23 | 43,511,538.37 | 43,512,890.83 | 43,515,016.12 |
| 资本公积 | 228,915,171.79 | 228,224,791.45 | 228,216,954.78 | 228,204,761 |
| 减:库存股 | 101,017,583.6 | 101,017,583.6 | 101,017,583.6 | 101,017,583.6 |
| 其他综合收益 | 19,570,914.46 | 23,098,912.4 | 5,651,212.28 | -6,257,250.18 |
| 盈余公积 | 228,578,647.53 | 228,578,647.53 | 228,578,647.53 | 228,578,647.53 |
| 未分配利润 | 2,209,952,438.43 | 2,309,032,540.67 | 2,389,225,439.3 | 2,442,485,224.08 |
| 归属于母公司股东权益合计 | 3,143,739,195.84 | 3,245,747,305.82 | 3,308,485,682.12 | 3,349,826,403.95 |
| 少数股东权益 | 603,017,232.05 | 615,387,300.25 | 628,917,494.27 | 632,554,318.33 |
| 股东权益合计 | 3,746,756,427.89 | 3,861,134,606.07 | 3,937,403,176.39 | 3,982,380,722.28 |
| 负债和股东权益合计 | 5,170,207,077.81 | 5,217,650,489.01 | 5,195,708,595.15 | 5,236,128,052.84 |
| 公告日期 | 2025-10-30 | 2025-08-27 | 2025-04-30 | 2025-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |